Novavax Inc (NVAX.O)

NVAX.O on Nasdaq

5.13USD
24 Oct 2014
Price Change (% chg)

$0.14 (+2.81%)
Prev Close
$4.99
Open
$5.02
Day's High
$5.25
Day's Low
$4.99
Volume
5,755,857
Avg. Vol
3,319,405
52-wk High
$6.95
52-wk Low
$2.68

NVAX.O

Chart for NVAX.O

About

Novavax, Inc. (Novavax) is a clinical stage biopharmaceutical company. The Company focuses on developing recombinant vaccines. The Company’s technology platform is based on recombinant vaccine technology that includes the virus-like particles (VLPs). The Company's vaccine candidates are genetically engineered three-dimensional... (more)

Overall

Beta: 1.21
Market Cap (Mil.): $1,189.68
Shares Outstanding (Mil.): 238.41
Dividend: --
Yield (%): --

Financials

  NVAX.O Industry Sector
P/E (TTM): -- 154.10 33.86
EPS (TTM): -0.31 -- --
ROI: -32.45 -1.61 17.53
ROE: -34.78 -6.70 18.34
Search Stocks

Competitors

  Price Change
Novartis AG (NOVN.VX) CHF85.75 +0.35
Merck & Co., Inc. (MRK.N) $57.61 +0.98
Sanofi SA (SASY.PA) €84.60 -0.30
GlaxoSmithKline plc (GSK.L) 1,415.50p +3.50
AstraZeneca plc (AZN.L) 4,327.50p -7.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks